SEC 13F Intelligence

American Century Companies Inc / LLY

American Century Companies Inc’s Eli Lilly & Co Position

Does American Century Companies Inc own Eli Lilly & Co (LLY)? Yes — 1.85M shares worth $1.7B (+0.87% of its 13F portfolio) as of Q1 2026, down from 1.86M shares the prior filed quarter.

Position Value
$1.7B
Q1 2026
Shares
1.85M
% of Portfolio
+0.87%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $46MQ4 ’18Q1 ’19: $47MQ2 ’19: $52MQ3 ’19: $32MQ4 ’19: $5MQ4 ’19Q1 ’20: $6MQ2 ’20: $9MQ3 ’20: $15MQ4 ’20: $6MQ4 ’20Q1 ’21: $8MQ2 ’21: $22MQ3 ’21: $7MQ4 ’21: $13MQ4 ’21Q1 ’22: $13MQ2 ’22: $160MQ3 ’22: $193MQ4 ’22: $430MQ4 ’22Q1 ’23: $520MQ2 ’23: $765MQ3 ’23: $1.0BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.5BQ2 ’24: $1.9BQ3 ’24: $2.0BQ4 ’24: $1.8BQ4 ’24Q1 ’25: $1.6BQ2 ’25: $1.4BQ3 ’25: $1.5BQ4 ’25: $2.0BQ4 ’25Q1 ’26: $1.7Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.85M$1.7B+0.87%
Q4 20251.86M$2.0B+1.01%
Q3 20251.96M$1.5B+0.76%
Q2 20251.84M$1.4B+0.78%
Q1 20251.97M$1.6B+1.00%
Q4 20242.30M$1.8B+1.02%
Q3 20242.26M$2.0B+1.17%
Q2 20242.07M$1.9B+1.15%
Q1 20241.97M$1.5B+0.96%
Q4 20231.98M$1.2B+0.79%
Q3 20231.93M$1.0B+0.80%
Q2 20231.63M$765M+0.58%
Q1 20231.51M$520M+0.41%
Q4 20221.17M$430M+0.35%
Q3 2022598.2K$193M+0.17%
Q2 2022492.5K$160M+0.13%
Q1 202243.8K$13M+0.01%
Q4 202146.8K$13M+0.01%
Q3 202130.5K$7M0.00%
Q2 202195.2K$22M+0.01%
Q1 202141.0K$8M+0.01%
Q4 202036.4K$6M0.00%
Q3 2020100.7K$15M+0.01%
Q2 202057.4K$9M+0.01%
Q1 202046.8K$6M+0.01%
Q4 201941.7K$5M+0.01%
Q3 2019288.3K$32M+0.03%
Q2 2019470.3K$52M+0.05%
Q1 2019363.0K$47M+0.05%
Q4 2018399.4K$46M+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See American Century Companies Inc’s full portfolio or all institutional holders of LLY.